Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular membranes of antigen-presenting cells (APCs), such as dendritic cells, macrophages, and B cells, serve as the primary interface for initiating and regulating adaptive immune responses (Gaudino & Kumar, 2019). These membranes are characterized by the presence of Major Histocompatibility Complex (MHC) molecules, which present antigenic peptides to T-cell receptors, and a variety of costimulatory and coinhibitory molecules like CD80, CD86, and CD40 (Roche & Furuta, 2015). In the context of disease, APC membranes play a dual role: in cancer, they may lack sufficient costimulatory signals or overexpress inhibitory ligands, leading to immune evasion, while in autoimmune diseases, they may facilitate the overactivation of self-reactive T cells (Vonderheide, 2020). Pharmacological targeting of APC membranes typically involves monoclonal antibodies or fusion proteins that bind to specific surface receptors to either enhance or suppress immune signaling (Moreland et al., 2006). Furthermore, the use of APC-derived membranes to coat synthetic nanoparticles has emerged as a novel biomimetic strategy to improve drug delivery and vaccine efficacy by leveraging the natural homing and signaling capabilities of these cells (Fang et al., 2018).
Modulation of T-cell activation and immune signaling through the interaction with peptide-MHC complexes and costimulatory or coinhibitory surface molecules.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes of antigen-presenting cells (APC membranes).